Feb 5 (Reuters) - Indian drugmaker Alembic Pharmaceuticals (ALEM.NS), opens new tab on Thursday reported lower third‑quarter profit on Thursday after taking a one-time charge linked to India's new ...

Alembic City, a flagship integrated development by Alembic Real Estate in Bengaluru's Whitefield, has reached a significant milestone. A renowned global technology company has leased 2.4 million sq.

Alembic Pharmaceuticals Ltd received final approval from the USFDA for its generic Difluprednate ophthalmic emulsion, used to treat eye inflammation and pain post-surgery. This approval marks a ...

Fintel reports that on January 15, 2026, Alembic Global initiated coverage of ATI (NYSE:ATI) with a Overweight recommendation. Analyst Price Forecast Suggests 1.04% Downside As of January 14, 2026, ...

No TypeScript, No JavaScript, No Jinja2 100% Python. Type-safe, declarative HTML building and modern web app features with minimal stack. Ideal for Python developers who want to build modern web apps ...

Alembic Pharmaceuticals was hit with a patent infringement lawsuit on Dec. 19 in New York Eastern District Court over its planned generic version of the glaucoma treatment LUMIGAN®. The action, ...

Alembic Pharmaceuticals was sued for patent infringement on Dec. 19 in New York Eastern District Court for seeking to market a generic version of glaucoma treatment Lumigan. The action, brought by ...

International consultancy Accenture announced last week that it had invested in AI startup Alembic, kickstarting a partnership that will leverage the technology to better measure the effectiveness of ...

Led by Prysm Capital and Accenture with participation from Silver Lake Waterman, Liquid 2 Ventures, NextEquity, Friends & Family Capital, and WndrCo, this round positions Alembic among the top AI labs ...

Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...

Alembic, a startup that offers AI-powered data analytics for marketers, said it has raised $145 million in a fundraising round that values the company at $645 million. Alembic’s software is designed ...

Alembic Technologies has raised $145 million in Series B and growth funding at a valuation 15 times higher than its previous round, betting that the next competitive advantage in artificial ...